New hope for stiff person syndrome: drug trial aims to ease muscle stiffness and improve walking
NCT ID NCT07552987
First seen Apr 28, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study tests a medicine called IGIV 10% (a purified antibody solution) against a placebo in 38 adults aged 18-70 with stiff person syndrome, a rare condition causing muscle stiffness and spasms. The main goal is to see if the drug helps people walk faster over 25 feet. Researchers will also check for changes in stiffness and safety over 24 to 48 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STIFF PERSON SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.